Cerebras in Q2 13Fs: Who Bought the AI Chip IPO

Fresh IPOs are a special case in 13F research. There is no prior-quarter holder list, so every position in the first filing is a "new buy" by definition. That makes it easy to over-read the data, but it also gives you a clean look at who wanted in from day one. Cerebras Systems (CBRS), the AI chipmaker that went public in the spring, is a good example.

How crowded was the opening?

According to one aggregator's summary of the 299 most focused 13F books, Cerebras was opened as a new position by about 19 funds in Q2 2026, with roughly $4.7 billion in aggregate value. That put it second only to SpaceX among the most-opened positions of the quarter, and ahead of Nvidia on the count of brand-new stakes. Information technology names made up six of the ten most-opened positions overall, which fits the broader AI-hardware theme we have tracked in recent weeks.

The biggest holders

Per InsiderSet's institutional ownership page, the largest reported Q2 holders were:

• Eclipse Operations, LLC: about 11.4 million shares, roughly $2.53 billion
• FMR LLC (Fidelity): about 8.4 million shares, roughly $1.86 billion
• Altimeter Capital Management: about 7.2 million shares, roughly $1.60 billion
• Coatue Management: about 7.0 million shares, roughly $1.55 billion
• Atreides Management: about 3.1 million shares, roughly $687 million
• Tiger Global Management: about 3.0 million shares, roughly $663 million

The page tracks 412 institutional holders in total, with the top ten accounting for roughly 61% of the disclosed value. That is a concentrated register. When a handful of holders own most of the institutional float, the stock's path depends heavily on whether those few stay put.

Notice who is on the list: growth-oriented, technology-focused managers such as Altimeter, Coatue, and Tiger Global, alongside the big index-and-mutual-fund complexes. Tiger Global's addition was also flagged in Seeking Alpha's coverage of its top Q2 trades. You can see which of your tracked managers share this kind of tech-growth exposure on the InvestorLens overlap page.

Three cautions when reading an IPO's first 13F

The numbers are stale. These are June 30 positions, public in mid-August. The aggregator itself notes that this is "where money WAS, not where it is now." One estimate on the InsiderSet page suggests the largest holder's current position is worth far less than its quarter-end value, but that is a third-party calculation we could not verify, so treat it as a prompt to check the next filing rather than a fact.

Early holders may have had allocations, not convictions. IPO allocations often go to large institutions that are expected to hold. A position opened at the offering is a different signal from one built over months in the open market. The 13F cannot tell you which is which.

Price moves distort dollar values. A big gain between IPO and quarter-end inflates reported value even if no one bought a single extra share. Compare share counts across quarters, not dollars.

What to watch in the Q3 filings

The next set of 13Fs, covering September 30 positions, is due by mid-November. For Cerebras, the questions are straightforward. Did the early growth-fund holders add, hold, or trim? Did more value-oriented or macro funds show up? And did the share count at the top holders change, or only the dollar value? You can follow these shifts fund by fund on the investors page and see aggregate buying and selling on the flow page.

The takeaway

A crowded first-quarter holder list tells you that sophisticated money wanted exposure to AI chips and that it was willing to pay up for a newly public name. It does not tell you whether that conviction lasted. The real information arrives one quarter later, when you can see who kept their shares. Treat the first filing as a baseline, and let the second one do the talking.

---

Data sourced from public SEC 13F filings. Educational research only — not investment advice.